This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Cygnet Biosciences B.v.. Active years: 2018.
Company Filing History:
Years Active: 2018
Title: Stefania Sanfilippo: Innovator in Chitinase Inhibitors
Introduction
Stefania Sanfilippo is a prominent inventor based in Siena, Italy. She has made significant contributions to the field of pharmaceuticals, particularly in the development of chitinase inhibitors. Her innovative work has the potential to impact the treatment of fungal infections.
Latest Patents
Stefania holds a patent for "Macrocyclic amidinourea derivatives, methods of preparation and uses thereof as chitinase inhibitors." This invention relates to macrocyclic amidinourea derivatives, which are designed to be used as pharmaceutical compositions in the treatment of fungal infections. The patent highlights the methods of preparation and the various applications of these derivatives.
Career Highlights
Stefania is associated with Cygnet Biosciences B.V., where she continues to advance her research and development efforts. Her work is characterized by a commitment to innovation and excellence in the pharmaceutical industry.
Collaborations
Stefania has collaborated with notable colleagues, including Giorgio Maccari and Brunella Posteraro. These partnerships have fostered a collaborative environment that enhances the research and development process.
Conclusion
Stefania Sanfilippo is a trailblazer in the field of chitinase inhibitors, with her patent showcasing her innovative spirit and dedication to improving healthcare solutions. Her contributions are paving the way for advancements in the treatment of fungal infections.